111 related articles for article (PubMed ID: 4994945)
1. [Metabolism and toxicity of therapeutic chelating agents. 9. Metabolization of EDTA and DTPA].
Zorn H
Strahlentherapie; 1970 Oct; 140(4):452-9. PubMed ID: 4994945
[No Abstract] [Full Text] [Related]
2. [Metabolism and toxicity of therapeutic chelating agents. 4. Excretion and metabolic degradation of EDTA and DTPA].
Havlícek F; Bohne F; Zorn H
Strahlentherapie; 1968 Nov; 136(5):604-8. PubMed ID: 4974440
[No Abstract] [Full Text] [Related]
3. [Metabolism and toxicity of therapeutic chelating agents. 5. Physiological dilution space of EDTA and DTPA].
Bohne F; Harmuth-Hoene AE; Kürzinger K; Havlícek F
Strahlentherapie; 1968 Nov; 136(5):609-16. PubMed ID: 4974441
[No Abstract] [Full Text] [Related]
4. [Metabolism and toxicity of therapeutic chelating agents. I. Comparative studies on the excretion of EDTA and DTPA in the rat urine].
Harmuth-Hoene AE
Strahlentherapie; 1967 Sep; 134(1):110-22. PubMed ID: 4967657
[No Abstract] [Full Text] [Related]
5. [Metabolism and toxicity of therapeutic chelating agents. 3. Effect of EDTA and DTPA on the excretion of endogenous zinc].
Havlicek F
Strahlentherapie; 1967 Oct; 134(2):296-305. PubMed ID: 4970734
[No Abstract] [Full Text] [Related]
6. 51Cr EDTA and 51Cr DTPA: renal diagnostic agents influence of the method of preparation on their biological behaviour.
Anghileri LJ
Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):238-44. PubMed ID: 4989615
[No Abstract] [Full Text] [Related]
7. [Metabolism and toxicity of therapeutic chelating agents. 7. Blood chemical andhematologic screening tests].
Seidel A
Strahlentherapie; 1970 May; 139(5):603-10. PubMed ID: 4994079
[No Abstract] [Full Text] [Related]
8. [Metabolism and toxicity of therapeutic chelating agents. 8. Excretion of sodium, potassium, magnesium and zinc].
Dvorak P
Strahlentherapie; 1970 May; 139(5):611-8. PubMed ID: 4994080
[No Abstract] [Full Text] [Related]
9. [Metabolism and toxicity of therapeutic chelating agents. 6. Histoautoradiographic localization of EDTA in rat organs].
Weber KM
Strahlentherapie; 1969 Jun; 137(6):708-11. PubMed ID: 4982212
[No Abstract] [Full Text] [Related]
10. Recent developments in chelate degradation.
Sillanpää M; Pirkanniemi K
Environ Technol; 2001 Jul; 22(7):791-801. PubMed ID: 11506204
[TBL] [Abstract][Full Text] [Related]
11. [Metabolism and toxicity of therapeutic chelating agents. II. Effect of DTPA on the intestinal absorption of zinc].
Bohne F; Nigrović V; Harmuth-Hoene AE
Strahlentherapie; 1967 Oct; 134(2):293-5. PubMed ID: 5598697
[No Abstract] [Full Text] [Related]
12. Degradation of EDTA and DTPA in chlorine dioxide bleaching conditions.
Kettunen-Knuutila A; Saastamoinen S; Rämö J; Sillanpää M; Veijonen TP; Ala-Kaila K
Water Sci Technol; 2004; 50(3):141-4. PubMed ID: 15461408
[TBL] [Abstract][Full Text] [Related]
13. [Metabolism and toxicity of therapeutic chelating agents. 13. Effect of Ca-DTPA on Zn concentration in organs].
Auth U
Strahlentherapie; 1973 Oct; 146(4):490-7. PubMed ID: 4786478
[No Abstract] [Full Text] [Related]
14. [Decorporation of radionuclides (studies of radiomanganese)].
Kuhn A
Strahlentherapie; 1969 Jan; 137(1):101-9. PubMed ID: 4976683
[No Abstract] [Full Text] [Related]
15. [Metabolism and toxicity of therapeutic chelating agents. X. Excretion of endogenous manganese].
Nadolny W
Strahlentherapie; 1971; 141(1):100-5. PubMed ID: 5002888
[No Abstract] [Full Text] [Related]
16. Clinical usefulness of iron chelating agents.
Waxman HS; Brown EB
Prog Hematol; 1969; 6():338-73. PubMed ID: 4976246
[No Abstract] [Full Text] [Related]
17. Intracellular plutonium: removal by liposome-encapsulated chelating agent.
Rahman YE; Rosenthal MW; Cerny EA
Science; 1973 Apr; 180(4083):300-2. PubMed ID: 4633691
[TBL] [Abstract][Full Text] [Related]
18. [EDTA and DTPA labelled with Cr-51 and Co-58 in renal diagnosis].
Deckart H; Herzmann H; Roick H
Med Klin; 1969 Oct; 64(41):1858-61. PubMed ID: 4990701
[No Abstract] [Full Text] [Related]
19. [Metabolism and toxicity of therapeutic chelating agents. XII. Effect on DNA synthesis in crypt cells of rat intestine].
Bohne F
Strahlentherapie; 1972 Jan; 143(1):106-12. PubMed ID: 4625854
[No Abstract] [Full Text] [Related]
20. Effect of chelating agents on the stability of injectable isoniazid solutions.
Ammar HO; Ibrahim SA; Abd El-Mohsen MG
Pharmazie; 1982 Apr; 37(4):270-1. PubMed ID: 6808529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
